国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Methanocaldococcus jannaschii Glutamate synthase (MJ1351), partial CSB-YP688306MRU
CSB-EP688306MRU
CSB-BP688306MRU
CSB-MP688306MRU
CSB-EP688306MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Ribose-phosphate pyrophosphokinase (prs) CSB-YP688307MRU
CSB-EP688307MRU
CSB-BP688307MRU
CSB-MP688307MRU
CSB-EP688307MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1374 (MJ1374) CSB-YP688308MRU
CSB-EP688308MRU
CSB-BP688308MRU
CSB-MP688308MRU
CSB-EP688308MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Putative nitroreductase MJ1384 (MJ1384) CSB-YP688309MRU
CSB-EP688309MRU
CSB-BP688309MRU
CSB-MP688309MRU
CSB-EP688309MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1389 (MJ1389) CSB-YP688310MRU
CSB-EP688310MRU
CSB-BP688310MRU
CSB-MP688310MRU
CSB-EP688310MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1394 (MJ1394), partial CSB-YP688311MRU
CSB-EP688311MRU
CSB-BP688311MRU
CSB-MP688311MRU
CSB-EP688311MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1403 (MJ1403), partial CSB-YP688312MRU1
CSB-EP688312MRU1
CSB-BP688312MRU1
CSB-MP688312MRU1
CSB-EP688312MRU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorocebus aethiops Tripartite motif-containing protein 5 (TRIM5), partial CSB-YP688313DSU
CSB-EP688313DSU
CSB-BP688313DSU
CSB-MP688313DSU
CSB-EP688313DSU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1409 (MJ1409) CSB-YP688314MRU
CSB-EP688314MRU
CSB-BP688314MRU
CSB-MP688314MRU
CSB-EP688314MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Archaeal Lon protease (MJ1417), partial CSB-YP688315MRU
CSB-EP688315MRU
CSB-BP688315MRU
CSB-MP688315MRU
CSB-EP688315MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii tRNA-splicing endonuclease (endA) CSB-YP688316MRU
CSB-EP688316MRU
CSB-BP688316MRU
CSB-MP688316MRU
CSB-EP688316MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1432 (MJ1432) CSB-YP688317MRU
CSB-EP688317MRU
CSB-BP688317MRU
CSB-MP688317MRU
CSB-EP688317MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Cobalamin synthase (cobS), partial CSB-YP688318MRU1
CSB-EP688318MRU1
CSB-BP688318MRU1
CSB-MP688318MRU1
CSB-EP688318MRU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1442 (MJ1442), partial CSB-YP688319MRU1
CSB-EP688319MRU1
CSB-BP688319MRU1
CSB-MP688319MRU1
CSB-EP688319MRU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Modification methylase MjaII (mjaIIM), partial CSB-YP688320MRU
CSB-EP688320MRU
CSB-BP688320MRU
CSB-MP688320MRU
CSB-EP688320MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1455 (MJ1455) CSB-YP688321MRU
CSB-EP688321MRU
CSB-BP688321MRU
CSB-MP688321MRU
CSB-EP688321MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Adenine deaminase (ade), partial CSB-YP688322MRU
CSB-EP688322MRU
CSB-BP688322MRU
CSB-MP688322MRU
CSB-EP688322MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1466 (MJ1466) CSB-YP688323MRU
CSB-EP688323MRU
CSB-BP688323MRU
CSB-MP688323MRU
CSB-EP688323MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1472 (MJ1472), partial CSB-YP688324MRU
CSB-EP688324MRU
CSB-BP688324MRU
CSB-MP688324MRU
CSB-EP688324MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized aminotransferase MJ1479 (MJ1479) CSB-YP688325MRU
CSB-EP688325MRU
CSB-BP688325MRU
CSB-MP688325MRU
CSB-EP688325MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>